Mediolanum International Funds’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.9M Sell
91,350
-5,313
-5% -$1.82M 0.28% 78
2026
Q1
$33.7M Buy
96,663
+7,075
+8% +$2.52M 0.36% 64
2025
Q4
$29.4M Buy
89,588
+30,735
+52% +$9.75M 0.29% 74
2025
Q3
$16.1M Buy
58,853
+44,469
+309% +$12.9M 0.17% 141
2025
Q2
$3.99M Sell
14,384
-6,925
-32% -$1.96M 0.05% 270
2025
Q1
$6.54M Sell
21,309
-3,230
-13% -$954K 0.09% 217
2024
Q4
$6.35M Buy
24,539
+1,989
+9% +$590K 0.08% 212
2024
Q3
$7.26M Sell
22,550
-485
-2% -$159K 0.1% 199
2024
Q2
$6.75M Buy
23,035
+212
+0.9% +$62.3K 0.11% 182
2024
Q1
$6.53M Buy
+22,823
New +$6.68M 0.11% 198

Other funds holding AMGN

Mediolanum International Funds's AMGN Position: Q2 2026 in Review

Mediolanum International Funds reduced its Amgen (AMGN) stake by 5.5% in Q2 2026, selling an estimated $1.82M and leaving 91,350 shares worth $32.9M. The position accounts for 0.28% of the portfolio, ranked #78.

Mediolanum International Funds first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $33.7M in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mediolanum International Funds held 91,350 shares of Amgen worth $32.9M as of Q2 2026.
  • Mediolanum International Funds sold 5,313 Amgen shares in Q2 2026, an estimated $1.82M.
  • Amgen made up 0.28% of Mediolanum International Funds's portfolio in Q2 2026, its #78 holding.
  • Mediolanum International Funds first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's Amgen position peaked at $33.7M in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.